Psoriatic patients without MS after narrowband ultraviolet B ( NB-UVB) therapy showed a much less reduction of systemic biomarkers (IL-17, TNF-α, IL-6) in comparison to patients without MS. This evidence concerns the gene TNF and myeloid sarcoma.